{"id":"W4317877786","doi":"10.1200/jco.2023.41.4_suppl.553","title":"Outcomes of patients with hepatocellular carcinoma (HCC) treated in the lenvatinib (LEN) and immunotherapy era (2018-2021) compared to the sorafenib (SOR) era (2008-2018).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sorafenib; Internal medicine; Lenvatinib; Hepatocellular carcinoma; Bevacizumab; Progression-free survival; Overall survival; Oncology; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002972531,0.0001584166,0.000279818,0.0004473197,0.0003481699,0.0003866461,0.000212634,0.0002475707,0.0008334328],"category_scores_gemma":[0.000813205,0.00009663522,0.0003429763,0.0006060814,0.0002553122,0.0002664784,0.0003402828,0.0003946971,0.0001318719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001760752,"about_ca_system_score_gemma":0.001071007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02575559,"about_ca_topic_score_gemma":0.05709865,"domain_scores_codex":[0.9997764,0.00002717299,0.00001867656,0.0000358125,0.00005884706,0.00008295869],"domain_scores_gemma":[0.9992519,0.00005783435,0.0003626542,0.00001322496,0.00008665056,0.0002277902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000963869,0.00007105332,0.9960389,0.00001853526,0.00006421864,0.0001119561,0.00006647861,0.0001156465,0.0001921305,0.00001274679,0.000253688,0.002090622],"study_design_scores_gemma":[0.00004610779,0.0005241351,0.9984963,0.000007927427,0.00005102207,0.000233059,0.0001747449,0.0001487885,0.00006047776,0.00001376365,0.0002395784,0.00000411731],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989383,0.0002330261,0.00001170958,0.00003993388,0.000004942657,0.000008788747,0.0003940127,0.000001307789,0.0003679947],"genre_scores_gemma":[0.9988552,0.00008354307,0.00001422499,0.00002389731,0.000009510035,0.000007621514,0.0008949816,5.168749e-7,0.0001104302],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02575559,"threshold_uncertainty_score":0.05121136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1301184676285087,"score_gpt":0.363535147823549,"score_spread":0.2334166801950402,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}